IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $15,635,000 | +200.0% | 258,813 | +219.2% | 0.30% | +200.0% |
Q2 2019 | $5,212,000 | -78.4% | 81,088 | -72.8% | 0.10% | -79.6% |
Q1 2019 | $24,174,000 | +20.2% | 297,815 | -19.9% | 0.50% | -2.0% |
Q4 2018 | $20,112,000 | +5.4% | 372,029 | +0.6% | 0.50% | +28.2% |
Q3 2018 | $19,084,000 | +24.0% | 369,985 | +0.2% | 0.39% | +12.6% |
Q2 2018 | $15,389,000 | +5.9% | 369,318 | +12.0% | 0.35% | +0.3% |
Q1 2018 | $14,538,000 | +237.4% | 329,820 | +285.0% | 0.35% | +229.2% |
Q4 2017 | $4,309,000 | -40.9% | 85,665 | -40.4% | 0.11% | -47.0% |
Q3 2017 | $7,293,000 | +3.5% | 143,842 | +3.8% | 0.20% | -2.0% |
Q2 2017 | $7,048,000 | -44.0% | 138,545 | -55.8% | 0.20% | -40.9% |
Q1 2017 | $12,591,000 | -38.0% | 313,202 | -26.2% | 0.34% | -39.2% |
Q4 2016 | $20,311,000 | +95.2% | 424,646 | +49.6% | 0.57% | +94.2% |
Q3 2016 | $10,403,000 | +10.0% | 283,936 | -30.1% | 0.29% | +11.0% |
Q2 2016 | $9,459,000 | +138.7% | 406,145 | +315.0% | 0.26% | +143.5% |
Q1 2016 | $3,963,000 | -64.3% | 97,861 | -45.5% | 0.11% | -61.3% |
Q4 2015 | $11,116,000 | – | 179,499 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |